SlideShare a Scribd company logo
Overview of ICH E9:  Statistical Principles for Clinical Trials         Presented by Jeff Davidson
ICH E9 cover page ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Scope and Direction
[object Object],[object Object],[object Object],[object Object],Unjustified statistics are like smiling cats - not to be trusted.  Scope and Direction
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Scope and Direction
[object Object],[object Object],[object Object],Scope and Direction
[object Object],[object Object],[object Object],Protocol and Analysis Plan
Types of Trials ,[object Object],Confirmatory Trial
Exploratory Trial ,[object Object],[object Object]
Confirmatory Trial ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Population ,[object Object],[object Object],[object Object],[object Object]
Outcome Variables ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Avoiding Bias by Design: Blinding ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Avoiding Bias by Design: Randomization ,[object Object],[object Object],[object Object]
[object Object],[object Object],Design Configuration Population A B
[object Object],[object Object],[object Object],[object Object],Design Configuration Population A B B A
[object Object],Design Configuration Population A (A1, A2) B (B1,B2) A1, B1 A1, B2 A2, B1 A2, B2
Other Study Designs ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Type of Comparison ,[object Object],[object Object],[object Object],[object Object],[object Object]
Type of Comparison ,[object Object],[object Object],[object Object],[object Object],[object Object]
Type of Comparison ,[object Object],[object Object],[object Object],[object Object]
 
Type of comparison ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Sample Size ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Data Monitoring ,[object Object],[object Object]
Oversight of Trial Quality ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Monitoring Treatment Effects: Interim Analysis ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Monitoring Treatment Effects: Interim Analysis  ,[object Object],Independent  Statistical Team Study Team IRB Sponsor DMC
Monitoring Treatment Effects: Interim Analysis ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Data Analysis ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Analysis Sets ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Full Analysis Set ,[object Object],[object Object],[object Object]
Full Analysis Set ,[object Object],[object Object],[object Object],[object Object],[object Object]
Per Protocol Set ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Estimation and Confidence Intervals ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Evaluation of Safety ,[object Object],[object Object],[object Object]
Example of an  unacceptable  adverse event
Evaluation of Safety is  critical to the success  of a new drug
Reporting ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object]

More Related Content

What's hot

Clinical trial design
Clinical trial designClinical trial design
Clinical trial design
SaajidHameed1
 
Randomized clinical trials
Randomized clinical trialsRandomized clinical trials
Randomized clinical trials
Ahmed Nouri
 
CDISC-CDASH
CDISC-CDASHCDISC-CDASH
CDISC-CDASH
Gowthami6789
 
Clinical trial design
Clinical trial designClinical trial design
Clinical trial designUrmila Aswar
 
Case Report Form (CRF)
Case Report Form (CRF)Case Report Form (CRF)
Case Report Form (CRF)
Neelam Shinde
 
Turacoz - Clinical Study Report
Turacoz - Clinical Study ReportTuracoz - Clinical Study Report
Turacoz - Clinical Study Report
Turacoz Healthcare Solutions
 
Interim Analysis of Clinical Trial Data: Implementation and Practical Advice
Interim Analysis of Clinical Trial Data: Implementation and Practical AdviceInterim Analysis of Clinical Trial Data: Implementation and Practical Advice
Interim Analysis of Clinical Trial Data: Implementation and Practical Advice
NAMSA
 
Clinical trial design, Trial Size, and Study Population
Clinical trial design, Trial Size, and Study Population Clinical trial design, Trial Size, and Study Population
Clinical trial design, Trial Size, and Study Population
Shubham Chinchulkar
 
Adaptive Study Designs
Adaptive Study DesignsAdaptive Study Designs
Adaptive Study Designs
Anirudha Potey
 
Statistical analysis of clinical data
Statistical analysis of clinical dataStatistical analysis of clinical data
Statistical analysis of clinical data
Darshil Shah
 
Data management & statistics in clinical trials
Data management & statistics in clinical trialsData management & statistics in clinical trials
Data management & statistics in clinical trials
International Islamic University Malaysia
 
Helsinki declaration
Helsinki declarationHelsinki declaration
Helsinki declaration
Simran Narang
 
ICH GCP
ICH GCPICH GCP
Ich e6(r1)
Ich e6(r1)Ich e6(r1)
Ich e6(r1)
ManishaChauhan86
 
Drug and safety monitoring board
Drug and safety  monitoring boardDrug and safety  monitoring board
Drug and safety monitoring board
Ramakanth Gadepalli
 
Understanding clinical trial's statistics
Understanding clinical trial's statisticsUnderstanding clinical trial's statistics
Understanding clinical trial's statistics
Magdy Khames Aly
 
Workflow of CDM
Workflow of CDMWorkflow of CDM
Workflow of CDM
ClinosolIndia
 
The basics of clinical trials
The basics of clinical trialsThe basics of clinical trials
The basics of clinical trials
BIG_against_breast_cancer
 
Safety_Data_Reconciliation_Katalyst HLS
Safety_Data_Reconciliation_Katalyst HLSSafety_Data_Reconciliation_Katalyst HLS
Safety_Data_Reconciliation_Katalyst HLS
Katalyst HLS
 

What's hot (20)

Clinical trial design
Clinical trial designClinical trial design
Clinical trial design
 
Randomized clinical trials
Randomized clinical trialsRandomized clinical trials
Randomized clinical trials
 
CDISC-CDASH
CDISC-CDASHCDISC-CDASH
CDISC-CDASH
 
Clinical trial design
Clinical trial designClinical trial design
Clinical trial design
 
Case Report Form (CRF)
Case Report Form (CRF)Case Report Form (CRF)
Case Report Form (CRF)
 
Qc in clinical trials
Qc in clinical trialsQc in clinical trials
Qc in clinical trials
 
Turacoz - Clinical Study Report
Turacoz - Clinical Study ReportTuracoz - Clinical Study Report
Turacoz - Clinical Study Report
 
Interim Analysis of Clinical Trial Data: Implementation and Practical Advice
Interim Analysis of Clinical Trial Data: Implementation and Practical AdviceInterim Analysis of Clinical Trial Data: Implementation and Practical Advice
Interim Analysis of Clinical Trial Data: Implementation and Practical Advice
 
Clinical trial design, Trial Size, and Study Population
Clinical trial design, Trial Size, and Study Population Clinical trial design, Trial Size, and Study Population
Clinical trial design, Trial Size, and Study Population
 
Adaptive Study Designs
Adaptive Study DesignsAdaptive Study Designs
Adaptive Study Designs
 
Statistical analysis of clinical data
Statistical analysis of clinical dataStatistical analysis of clinical data
Statistical analysis of clinical data
 
Data management & statistics in clinical trials
Data management & statistics in clinical trialsData management & statistics in clinical trials
Data management & statistics in clinical trials
 
Helsinki declaration
Helsinki declarationHelsinki declaration
Helsinki declaration
 
ICH GCP
ICH GCPICH GCP
ICH GCP
 
Ich e6(r1)
Ich e6(r1)Ich e6(r1)
Ich e6(r1)
 
Drug and safety monitoring board
Drug and safety  monitoring boardDrug and safety  monitoring board
Drug and safety monitoring board
 
Understanding clinical trial's statistics
Understanding clinical trial's statisticsUnderstanding clinical trial's statistics
Understanding clinical trial's statistics
 
Workflow of CDM
Workflow of CDMWorkflow of CDM
Workflow of CDM
 
The basics of clinical trials
The basics of clinical trialsThe basics of clinical trials
The basics of clinical trials
 
Safety_Data_Reconciliation_Katalyst HLS
Safety_Data_Reconciliation_Katalyst HLSSafety_Data_Reconciliation_Katalyst HLS
Safety_Data_Reconciliation_Katalyst HLS
 

Viewers also liked

ICH E9 (Statistical Principles for Clinical Trials E9)
ICH E9 (Statistical Principles for Clinical Trials E9)ICH E9 (Statistical Principles for Clinical Trials E9)
ICH E9 (Statistical Principles for Clinical Trials E9)
PHARMADVISOR
 
Ich Fda Socra 09 2007
Ich Fda Socra 09 2007Ich Fda Socra 09 2007
Ich Fda Socra 09 2007jsf5328
 
Surrogate endpoints: a regulatory review
Surrogate endpoints: a regulatory reviewSurrogate endpoints: a regulatory review
Surrogate endpoints: a regulatory review
Tim Felgate
 
FDA 2013 Clinical Investigator Training Course: Clinical Trial Endpoints
FDA 2013 Clinical Investigator Training Course: Clinical Trial EndpointsFDA 2013 Clinical Investigator Training Course: Clinical Trial Endpoints
FDA 2013 Clinical Investigator Training Course: Clinical Trial Endpoints
MedicReS
 
Ethical guidelines of clinical trials.
Ethical guidelines of clinical trials.Ethical guidelines of clinical trials.
Ethical guidelines of clinical trials.Ashu Koli
 
History ethical guide lines to clinical trial
History ethical guide lines to clinical trialHistory ethical guide lines to clinical trial
History ethical guide lines to clinical trial
Anju Thejkumar
 
Clinical practice guidelines
Clinical practice guidelinesClinical practice guidelines
Clinical practice guidelinesabenedicto
 
Parkinsonism.ppt
Parkinsonism.pptParkinsonism.ppt
Parkinsonism.pptShama
 
Drug distribution & drug elimination pharmacology
Drug distribution & drug elimination pharmacologyDrug distribution & drug elimination pharmacology
Drug distribution & drug elimination pharmacology
Vishnu Priya
 
ICH
ICHICH
Parkinson’S Disease
Parkinson’S DiseaseParkinson’S Disease
Parkinson’S Diseaseguest27ee33
 
ICH GUIDELINES
ICH GUIDELINESICH GUIDELINES
ICH GUIDELINES
Naveen Kumar
 
Clinical Trial Phases
Clinical Trial PhasesClinical Trial Phases
Clinical Trial Phases
Dr. Ashutosh Tiwari
 
ICH Guideline Q9 - Quality Risk Management
ICH Guideline Q9 - Quality Risk ManagementICH Guideline Q9 - Quality Risk Management
ICH Guideline Q9 - Quality Risk Management
muna_ali
 
Clinical Pathways
Clinical PathwaysClinical Pathways
Clinical Pathwayspradhasrini
 
Clinical Trials - An Introduction
Clinical Trials - An IntroductionClinical Trials - An Introduction
Clinical Trials - An Introduction
Dr Purnendu Sekhar Das
 

Viewers also liked (17)

ICH E9 (Statistical Principles for Clinical Trials E9)
ICH E9 (Statistical Principles for Clinical Trials E9)ICH E9 (Statistical Principles for Clinical Trials E9)
ICH E9 (Statistical Principles for Clinical Trials E9)
 
Ich Fda Socra 09 2007
Ich Fda Socra 09 2007Ich Fda Socra 09 2007
Ich Fda Socra 09 2007
 
Surrogate endpoints: a regulatory review
Surrogate endpoints: a regulatory reviewSurrogate endpoints: a regulatory review
Surrogate endpoints: a regulatory review
 
FDA 2013 Clinical Investigator Training Course: Clinical Trial Endpoints
FDA 2013 Clinical Investigator Training Course: Clinical Trial EndpointsFDA 2013 Clinical Investigator Training Course: Clinical Trial Endpoints
FDA 2013 Clinical Investigator Training Course: Clinical Trial Endpoints
 
Ethical guidelines of clinical trials.
Ethical guidelines of clinical trials.Ethical guidelines of clinical trials.
Ethical guidelines of clinical trials.
 
History ethical guide lines to clinical trial
History ethical guide lines to clinical trialHistory ethical guide lines to clinical trial
History ethical guide lines to clinical trial
 
Clinical practice guidelines
Clinical practice guidelinesClinical practice guidelines
Clinical practice guidelines
 
Parkinsonism.ppt
Parkinsonism.pptParkinsonism.ppt
Parkinsonism.ppt
 
Drug distribution & drug elimination pharmacology
Drug distribution & drug elimination pharmacologyDrug distribution & drug elimination pharmacology
Drug distribution & drug elimination pharmacology
 
ICH
ICHICH
ICH
 
Ich guidelines
Ich guidelinesIch guidelines
Ich guidelines
 
Parkinson’S Disease
Parkinson’S DiseaseParkinson’S Disease
Parkinson’S Disease
 
ICH GUIDELINES
ICH GUIDELINESICH GUIDELINES
ICH GUIDELINES
 
Clinical Trial Phases
Clinical Trial PhasesClinical Trial Phases
Clinical Trial Phases
 
ICH Guideline Q9 - Quality Risk Management
ICH Guideline Q9 - Quality Risk ManagementICH Guideline Q9 - Quality Risk Management
ICH Guideline Q9 - Quality Risk Management
 
Clinical Pathways
Clinical PathwaysClinical Pathways
Clinical Pathways
 
Clinical Trials - An Introduction
Clinical Trials - An IntroductionClinical Trials - An Introduction
Clinical Trials - An Introduction
 

Similar to Overview Of Ich New E9

Clinical trials
Clinical trials Clinical trials
Clinical trials
waseem rather
 
9-Meta Analysis/ Systematic Review
9-Meta Analysis/ Systematic Review9-Meta Analysis/ Systematic Review
9-Meta Analysis/ Systematic Review
ResearchGuru
 
RCT to causal inference.pptx
RCT to causal inference.pptxRCT to causal inference.pptx
RCT to causal inference.pptx
Francois MAIGNEN
 
When to Select Observational Studies as Evidence for Comparative Effectivenes...
When to Select Observational Studies as Evidence for Comparative Effectivenes...When to Select Observational Studies as Evidence for Comparative Effectivenes...
When to Select Observational Studies as Evidence for Comparative Effectivenes...Effective Health Care Program
 
EBM Therapy Appraisal Template F1
EBM Therapy Appraisal Template F1EBM Therapy Appraisal Template F1
EBM Therapy Appraisal Template F1
Imad Hassan
 
NES Pharmacy, Critical Appraisal 2011
NES Pharmacy, Critical Appraisal 2011NES Pharmacy, Critical Appraisal 2011
NES Pharmacy, Critical Appraisal 2011
NES
 
# 9th lect clinical trial analysis
# 9th lect  clinical  trial analysis# 9th lect  clinical  trial analysis
# 9th lect clinical trial analysis
Dr. Eman M. Mortada
 
Randomized controlled trials
Randomized controlled trialsRandomized controlled trials
JC SEBMA Prognosis Appraisal Template V1
JC SEBMA Prognosis Appraisal Template V1JC SEBMA Prognosis Appraisal Template V1
JC SEBMA Prognosis Appraisal Template V1
Imad Hassan
 
research design
research designresearch design
research designRajeshwori
 
Research Methodology - Dr Kusum Gaur
Research Methodology - Dr Kusum GaurResearch Methodology - Dr Kusum Gaur
Research Methodology - Dr Kusum Gaur
mrinal joshi
 
biostatists presentation
biostatists presentationbiostatists presentation
biostatists presentationAnil kumar
 
HLinc presentation: levels of evidence
HLinc presentation:  levels of evidenceHLinc presentation:  levels of evidence
HLinc presentation: levels of evidence
CatherineVoutier
 
Doc 20181126-wa0018
Doc 20181126-wa0018Doc 20181126-wa0018
Doc 20181126-wa0018
siwaniteki
 
Metaanalysis copy
Metaanalysis    copyMetaanalysis    copy
Metaanalysis copy
Amandeep Kaur
 
Systematic Reviews Class 4c
Systematic Reviews Class 4cSystematic Reviews Class 4c
Systematic Reviews Class 4cguestf5d7ac
 
Eblm pres final
Eblm pres finalEblm pres final
Eblm pres finalprasath172
 
bio equivalence studies
bio equivalence studiesbio equivalence studies
bio equivalence studies
RamyaP53
 

Similar to Overview Of Ich New E9 (20)

Clinical trials
Clinical trials Clinical trials
Clinical trials
 
9-Meta Analysis/ Systematic Review
9-Meta Analysis/ Systematic Review9-Meta Analysis/ Systematic Review
9-Meta Analysis/ Systematic Review
 
RCT to causal inference.pptx
RCT to causal inference.pptxRCT to causal inference.pptx
RCT to causal inference.pptx
 
When to Select Observational Studies as Evidence for Comparative Effectivenes...
When to Select Observational Studies as Evidence for Comparative Effectivenes...When to Select Observational Studies as Evidence for Comparative Effectivenes...
When to Select Observational Studies as Evidence for Comparative Effectivenes...
 
Study Eligibility Criteria
Study Eligibility CriteriaStudy Eligibility Criteria
Study Eligibility Criteria
 
EBM Therapy Appraisal Template F1
EBM Therapy Appraisal Template F1EBM Therapy Appraisal Template F1
EBM Therapy Appraisal Template F1
 
NES Pharmacy, Critical Appraisal 2011
NES Pharmacy, Critical Appraisal 2011NES Pharmacy, Critical Appraisal 2011
NES Pharmacy, Critical Appraisal 2011
 
Ebd jc part 5
Ebd jc part 5Ebd jc part 5
Ebd jc part 5
 
# 9th lect clinical trial analysis
# 9th lect  clinical  trial analysis# 9th lect  clinical  trial analysis
# 9th lect clinical trial analysis
 
Randomized controlled trials
Randomized controlled trialsRandomized controlled trials
Randomized controlled trials
 
JC SEBMA Prognosis Appraisal Template V1
JC SEBMA Prognosis Appraisal Template V1JC SEBMA Prognosis Appraisal Template V1
JC SEBMA Prognosis Appraisal Template V1
 
research design
research designresearch design
research design
 
Research Methodology - Dr Kusum Gaur
Research Methodology - Dr Kusum GaurResearch Methodology - Dr Kusum Gaur
Research Methodology - Dr Kusum Gaur
 
biostatists presentation
biostatists presentationbiostatists presentation
biostatists presentation
 
HLinc presentation: levels of evidence
HLinc presentation:  levels of evidenceHLinc presentation:  levels of evidence
HLinc presentation: levels of evidence
 
Doc 20181126-wa0018
Doc 20181126-wa0018Doc 20181126-wa0018
Doc 20181126-wa0018
 
Metaanalysis copy
Metaanalysis    copyMetaanalysis    copy
Metaanalysis copy
 
Systematic Reviews Class 4c
Systematic Reviews Class 4cSystematic Reviews Class 4c
Systematic Reviews Class 4c
 
Eblm pres final
Eblm pres finalEblm pres final
Eblm pres final
 
bio equivalence studies
bio equivalence studiesbio equivalence studies
bio equivalence studies
 

Overview Of Ich New E9

  • 1. Overview of ICH E9: Statistical Principles for Clinical Trials Presented by Jeff Davidson
  • 2.
  • 3.
  • 4.
  • 5.
  • 6.
  • 7.
  • 8.
  • 9.
  • 10.
  • 11.
  • 12.
  • 13.
  • 14.
  • 15.
  • 16.
  • 17.
  • 18.
  • 19.
  • 20.
  • 21.
  • 22.
  • 23.  
  • 24.
  • 25.
  • 26.
  • 27.
  • 28.
  • 29.
  • 30.
  • 31.
  • 32.
  • 33.
  • 34.
  • 35.
  • 36.
  • 37.
  • 38. Example of an unacceptable adverse event
  • 39. Evaluation of Safety is critical to the success of a new drug
  • 40.
  • 41.